As a leading preclinical CRO, we work with pharmaceutical and biotech companies in developing treatments for CNS disorders, including Parkinson’s, movement, cognitive, and spinal cord injuries. With state-of-the-art facilities in Europe and Asia, we deliver expert consultancy, flexible laboratory research, and advanced stereotactic techniques, underpinning six clinical studies in 2024 derived from our preclinical work.